Pressure BioSciences Company Profile (OTCMKTS:PBIO)

About Pressure BioSciences (OTCMKTS:PBIO)

Pressure BioSciences logoPressure BioSciences, Inc. is focused on solving the problems inherent in biological sample preparation. The Company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels, such as approximately 35,000 pounds per square inch (psi) or greater to control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant and microbial sources. Its laboratory instrument, the Barocycler, and its consumables product line, which include its Pressure Used to Lyse Samples for Extraction (PULSE) tubes, and other processing tubes, and application specific kits, such as consumable products and reagents, together make up its PCT Sample Preparation System (PCT SPS). The Company is also the distributor for the Constant Systems cell disruption equipment, parts, and consumables.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Symbol: OTCMKTS:PBIO
  • CUSIP: N/A
  • Web: www.pressurebiosciences.com
Capitalization:
  • Market Cap: $4.84 million
  • Outstanding Shares: 1,101,000
Average Prices:
  • 50 Day Moving Avg: $3.99
  • 200 Day Moving Avg: $6.24
  • 52 Week Range: $0.70 - $11.40
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -27.50
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $2.05 million
  • Price / Sales: 2.36
  • Book Value: ($11.90) per share
  • Price / Book: -0.37
Profitability:
  • EBITDA: ($3,820,000.00)
  • Net Margins: -190.47%
  • Return on Assets: -547.67%
Debt:
  • Current Ratio: 0.14%
  • Quick Ratio: 0.06%
Misc:
  • Average Volume: 3,370 shs.
  • Beta: 1.67
  • Short Ratio: 3
 

Frequently Asked Questions for Pressure BioSciences (OTCMKTS:PBIO)

What is Pressure BioSciences' stock symbol?

Pressure BioSciences trades on the OTCMKTS under the ticker symbol "PBIO."

How were Pressure BioSciences' earnings last quarter?

Pressure BioSciences Inc. (OTCMKTS:PBIO) released its quarterly earnings results on Wednesday, August, 16th. The company reported ($0.54) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.90) by $0.36. The company had revenue of $0.54 million for the quarter, compared to analysts' expectations of $0.78 million. View Pressure BioSciences' Earnings History.

When will Pressure BioSciences make its next earnings announcement?

Pressure BioSciences is scheduled to release their next quarterly earnings announcement on Wednesday, November, 15th 2017. View Earnings Estimates for Pressure BioSciences.

Who are some of Pressure BioSciences' key competitors?

Who are Pressure BioSciences' key executives?

Pressure BioSciences' management team includes the folowing people:

  • Jeffery N. Peterson, Independent Chairman of the Board
  • Richard T. Schumacher, President, Chief Executive Officer, Treasurer, Secretary, Clerk, Director
  • Joseph L. Damasio Jr., Chief Financial Officer, Vice President - Finance
  • Edmund Y. Ting Ph.D., Senior Vice President - Engineering
  • Nathan P. Lawrence Ph.D., Vice President of Sales and Marketing
  • Alexander V. Lazarev Ph.D., Vice President - Research & Development
  • Michael S. Urdea, Director
  • Vito J. Mangiardi, Independent Director
  • Kevin A. Pollack, Independent Director

How do I buy Pressure BioSciences stock?

Shares of Pressure BioSciences can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pressure BioSciences' stock price today?

One share of Pressure BioSciences stock can currently be purchased for approximately $4.40.


MarketBeat Community Rating for Pressure BioSciences (OTCMKTS PBIO)
Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  24 (Vote Outperform)
Underperform Votes:  25 (Vote Underperform)
Total Votes:  49
MarketBeat's community ratings are surveys of what our community members think about Pressure BioSciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Pressure BioSciences (OTCMKTS:PBIO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A
Consensus Price Target History for Pressure BioSciences (OTCMKTS:PBIO)
Price Target History for Pressure BioSciences (OTCMKTS:PBIO)
Analysts' Ratings History for Pressure BioSciences (OTCMKTS:PBIO)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Pressure BioSciences (OTCMKTS:PBIO)
Earnings by Quarter for Pressure BioSciences (OTCMKTS:PBIO)
Earnings History by Quarter for Pressure BioSciences (OTCMKTS PBIO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/15/2017        
8/16/2017Q2 2017($0.90)($0.54)$0.78 million$0.54 millionViewN/AView Earnings Details
5/16/2017Q1 2017($0.18)$0.55 millionViewN/AView Earnings Details
8/17/2015($0.04)($0.09)$0.58 million$0.41 millionViewN/AView Earnings Details
4/1/2015($0.07)($0.09)$0.50 million$0.29 millionViewN/AView Earnings Details
11/17/2014($0.11)($0.07)$0.46 million$0.37 millionViewN/AView Earnings Details
8/14/2014($0.11)($0.05)$0.39 million$0.31 millionViewN/AView Earnings Details
5/15/2014($0.10)($0.25)$0.34 million$0.40 millionViewN/AView Earnings Details
4/2/2014($0.07)($0.14)ViewN/AView Earnings Details
8/15/2013Q2 2013($0.06)($0.10)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Pressure BioSciences (OTCMKTS:PBIO)
Current Year EPS Consensus Estimate: $-0.28 EPS
Next Year EPS Consensus Estimate: $-0.16 EPS

Dividends

Dividend History for Pressure BioSciences (OTCMKTS:PBIO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Pressure BioSciences (OTCMKTS:PBIO)
Insider Ownership Percentage: 20.80%
Insider Trades by Quarter for Pressure BioSciences (OTCMKTS:PBIO)
Insider Trades by Quarter for Pressure BioSciences (OTCMKTS:PBIO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/26/2014Richard T SchumacherCEOBuy13,200$0.30$3,960.00View SEC Filing  
9/13/2013Richard T SchumacherCEOBuy2,500$0.31$775.00View SEC Filing  
9/12/2013Richard T SchumacherCEOBuy20,500$0.30$6,150.00View SEC Filing  
9/9/2013Richard T SchumacherCEOBuy15,500$0.28$4,340.00View SEC Filing  
8/30/2013Michael S UrdeaDirectorBuy50,000$0.29$14,500.00View SEC Filing  
8/30/2013Richard T SchumacherCEOBuy10,000$0.29$2,900.00View SEC Filing  
8/28/2013Richard T SchumacherCEOBuy15,000$0.28$4,200.00View SEC Filing  
8/23/2013Richard T SchumacherCEOBuy20,000$0.27$5,400.00View SEC Filing  
8/21/2013Kevin PollackDirectorBuy10,000$0.28$2,800.00View SEC Filing  
10/8/2012Clayton A StruveMajor ShareholderBuy76,350$0.38$29,013.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Pressure BioSciences (OTCMKTS:PBIO)
Latest Headlines for Pressure BioSciences (OTCMKTS:PBIO)
Source:
DateHeadline
finance.yahoo.com logoCEO Richard T. Schumacher Discusses Pressure BioScience’s New Sales Team and Novel Products that are Fueling its Progressive Upturn
finance.yahoo.com - October 11 at 6:24 AM
finance.yahoo.com logoPressure BioSciences' Penetration in European Biopharma and High Pressure Markets Continuing to Expand via Multiple Scientific Presentations in Germany, Poland, and Ireland
finance.yahoo.com - October 11 at 6:24 AM
finance.yahoo.com logoPressure BioSciences, Inc. to Present at the 2017 Disruptive Growth Company Showcase in New York City on September 27, 2017
finance.yahoo.com - October 3 at 3:16 AM
finance.yahoo.com logoPressure BioSciences, Inc. Issued First Two Patents on Widely-Applicable, High Pressure-Based Ultra Shear Technology ("UST")
finance.yahoo.com - October 3 at 3:16 AM
finance.yahoo.com logoPressure BioSciences' Next-Generation Barocycler 2320EXTREME Named a Finalist in the Prestigious 2017 R&D 100 Awards
finance.yahoo.com - September 19 at 6:20 AM
finance.yahoo.com logoPressure BioSciences, Inc. to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City on September 11, 2017
finance.yahoo.com - September 12 at 8:26 AM
finance.yahoo.com logoPressure BioSciences, Inc. :PBIO-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
finance.yahoo.com - August 26 at 8:11 AM
americanbankingnews.com logoPressure BioSciences Inc. (PBIO) Releases Quarterly Earnings Results, Beats Estimates By $0.33 EPS
www.americanbankingnews.com - August 16 at 10:50 AM
finance.yahoo.com logoPressure BioSciences, Inc. to Discuss Second Quarter 2017 Financial Results and Provide Business Update
finance.yahoo.com - August 16 at 6:38 AM
biz.yahoo.com logoPRESSURE BIOSCIENCES INC Files SEC form 10-K, Annual Report
biz.yahoo.com - March 22 at 7:07 PM
bizjournals.com logoFinancialBuzz.com Innovation in the Sample Preparation Market
www.bizjournals.com - March 1 at 10:17 AM
biz.yahoo.com logoPRESSURE BIOSCIENCES INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - January 3 at 11:45 PM
biz.yahoo.com logoQ3 2016 Pressure Biosciences Inc Earnings Release - Time Not Supplied
biz.yahoo.com - November 16 at 10:27 AM

Social

Chart

Pressure BioSciences (PBIO) Chart for Tuesday, October, 17, 2017

This page was last updated on 10/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.